Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2010
04/28/2010CN101698032A Method for preparing tablets for treating hyperlipemia and prepared product
04/28/2010CN101698017A Antiphlogosis and sterilizing ointment
04/28/2010CN101698008A Antiviral capsules
04/28/2010CN101698005A Gold granules used for treating cold and influenza and preparation method thereof
04/28/2010CN101697998A Zhenhuang tablet for treating sore throat and ulcer and sore furuncle and preparation method thereof
04/28/2010CN101697988A Taste hiding composition and application thereof in Xuesaitong chewable tablet
04/28/2010CN101697978A Asparagus powder and chewable tablet as well as manufacturing method thereof
04/28/2010CN101697977A Deproteinized calf blood extractive injection and preparation method thereof
04/28/2010CN101697975A GSLS tablets used for animals and poultries and preparation method thereof
04/28/2010CN101697974A GSLS capsules used for animals and poultries and preparation method thereof
04/28/2010CN101697973A Cefathiamidine preparation for injection and preparation method thereof
04/28/2010CN101697970A Medicine composite for treating and relieving high blood pressure
04/28/2010CN101697968A Melatonin capsule
04/28/2010CN101697967A Adapalene-vitamin E compound cream and preparation method thereof
04/28/2010CN101697965A Inhalation capsules
04/28/2010CN101697964A Combretaftation A-4P frozen preparation and preparation method thereof
04/28/2010CN101697963A Method for preparing PLGA slow-release microsphere carrying docetaxel and application thereof in chemotherapy of mesenchyma stroma of tumors under ultrasonic mediation
04/28/2010CN101697962A Process for preparing matrine-loaded magnetic chitosan microspheres
04/28/2010CN101697961A New cefmenoxime hydrochloride preparation for drug administration by injection and preparation method thereof
04/28/2010CN101697960A Huperzine-A solid dispersion and method for preparing tablet thereof
04/28/2010CN101697959A Potassium sodium dehydroandrographolide succinate and sodium chloride injection and preparation method thereof
04/28/2010CN101697958A Standard dose traditional Chinese medicine decocted extract and preparation method thereof
04/27/2010USRE41286 cartilage regeneration and repair product that induces cell ingrowth into a bioresorbable material and cell differentiation into cartilage tissue; comprises at least one TGF beta protein and at least one bone morphogenetic protein
04/27/2010USRE41279 made by combining aqueous composition containing visual indicator and organic components and aqueous solution of salt of chlorous acid, preferably alkali metal chlorite; materials are blended into viscous material containing emollient package which generates active antimicrobial chlorine dioxide
04/27/2010USRE41278 useful to alleviate or improve various cosmetic conditions and dermatological disorders, including changes or damage to skin, nail and hair associated with intrinsic aging and/or extrinsic aging, as well as changes or damage caused by extrinsic factors
04/27/2010US7706873 System and method for controlled delivery of a therapeutic agent to a target location within an internal body tissue
04/27/2010US7705073 Mixture of thermoplastic resin with pulverized microbiocide; using bis(4-amino-1-pyridium)alkane
04/27/2010US7704985 luminally active anti-inflammatory or immunosuppressive compound with minimal or no systemic side effects
04/27/2010US7704977 Solid oral dosage form containing an enhancer
04/27/2010US7704975 Modafinil compound and cyclodextrin mixtures
04/27/2010US7704969 Transfection complexes
04/27/2010US7704962 Small oligonucleotides with anti-tumor activity
04/27/2010US7704954 Method and carrier complexes for delivering molecules to cells
04/27/2010US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer
04/27/2010US7704948 Stool softener and enteric coated bisacodyl; tablets, capsule; laxative; administering the drug
04/27/2010US7704534 Continuous process for production of oil seed protein isolate
04/27/2010US7704531 Enhanced efficacy aluminum or aluminum-zirconium antiperspirant salt compositions containing calcium salt(s) and betaine
04/27/2010US7704528 Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability
04/27/2010US7704527 A formulation of an extended release core of milnacipran or salt andan extended release excipient surrounded by a coating to delay drug release; side effect reduction; pharmacokinetics; lower daily dosage; antideppressants; fibromyalgia; unit dose of 25-500 mg for flexibility in time of day delivery
04/27/2010US7704526 Sustained release composition for oral administration of drugs
04/27/2010US7704525 Lipid microparticles by cryogenic micronization
04/27/2010US7704524 Transdermal botulinum toxin administration for the treatment of spastic muscle pain
04/27/2010US7704523 Microbial cellulose wound dressing for treating chronic wounds
04/27/2010US7704515 Composition and method to improve quality and yield of meat products
04/27/2010CA2651665C Process for preparing spray dried formulations of tmc125
04/27/2010CA2486571C Pharmaceutical composition
04/27/2010CA2476494C Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same
04/27/2010CA2461354C Fondant-based pharmaceutical composition
04/27/2010CA2438692C Injectable water-in-oil emulsions
04/27/2010CA2427482C Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride
04/27/2010CA2396376C Drug carrier pellet production process
04/27/2010CA2350246C Controlled delivery of active agents
04/27/2010CA2323696C Pharmaceutical composition based on natural synthesis progesterone and oestradiol and preparation method
04/27/2010CA2323102C Monolithic tablet for controlled drug release
04/27/2010CA2321926C Use of rhamnolipids in a composition for the treatment of signs of aging
04/27/2010CA2297998C Aqueous solution for use in the treatment of degenerative or autoimmune diseases and as an immunomodulatory agent
04/24/2010CA2641871A1 Pharmaceutical composition for treating alcohol-induced liver injury comprising (4s, 5s)-5-fluoromethyl-5-hydroxy-4-({[(5r)-5-isopropyl-3-(isoquinolin-1-yl)-4,5-dihydro-5-isoxazolyl]carbonyl}amino)-dihydrofuran-2-one or pharmaceutically acceptable salt thereof
04/22/2010WO2010045512A2 Processes and compositions for liposomal and efficient delivery of gene silencing therapeutics
04/22/2010WO2010045487A1 Device and method for delivery of therapeutic agents via internal implants
04/22/2010WO2010045479A1 Phospholipid micellar and liposomal compositions and uses thereof
04/22/2010WO2010045435A2 Salicylic acid composition
04/22/2010WO2010045431A2 Dry powder formulations, vaccines and methods
04/22/2010WO2010045292A2 Nanoparticle compositions comprising liquid oil cores
04/22/2010WO2010045281A2 Stable aqueous formulations of water insoluble or poorly soluble drugs
04/22/2010WO2010045209A2 Methods of treating pulmonary disorders with liposomal amikacin formulations
04/22/2010WO2010044867A1 Highly concentrated drug particles, formulations, suspensions and uses thereof
04/22/2010WO2010044857A1 Method for coating objects
04/22/2010WO2010044736A1 Multi portion intra-oral dosage form and use thereof
04/22/2010WO2010044679A1 Anti-infective formulation and methods of use
04/22/2010WO2010044597A2 Drug delivery device
04/22/2010WO2010044399A1 Automatic multifunctional liposome manufacturing device
04/22/2010WO2010044108A2 Controlled release formulations of ropinirole
04/22/2010WO2010044097A2 Novel dosage form of paliperidone and process for preparing the same
04/22/2010WO2010044089A1 Drug delivery system for econazole, moxifloxacin, and rifampicin
04/22/2010WO2010044085A1 Compositions and methods for treating varicose veins
04/22/2010WO2010044070A2 Synergistic composition for recovery and reduction of mild ischemic damage
04/22/2010WO2010043981A1 Method for treatment of copd and other pulmonary diseases
04/22/2010WO2010043950A2 Propafenone extended release composition
04/22/2010WO2010043832A1 Novel pharmaceutical uses for nanoparticles
04/22/2010WO2010043772A2 Method of protecting cells
04/22/2010WO2010043717A2 Pharmaceutical topical compositions
04/22/2010WO2010043630A2 A delivery system for rna
04/22/2010WO2010043446A2 Preparations for the controlled release of active agents
04/22/2010WO2010043408A2 Microencapsulated fesoterodine
04/22/2010WO2010043376A1 Tablet containing valsartan
04/22/2010WO2010043156A1 Drop pill for treating coronary heart disease and preparation thereof
04/22/2010WO2010043050A1 Combinations of a liposomal water-soluble camptothecin with cetuximab or bevacizumab
04/22/2010WO2010022276A3 Methods of processing multi-phasic dispersions
04/22/2010WO2010019643A9 An extracorporeal cell-based therapeutic device and delivery system
04/22/2010WO2010019413A3 Composite particles having an antioxidant-based protective system, and topical compositions comprising the same
04/22/2010WO2010014176A3 Preparation method of biodegradable micro-particles containing drugs
04/22/2010WO2010014172A3 Delivery particle
04/22/2010WO2010011319A8 Magnetic heating for drug delivery and other applications
04/22/2010WO2010009116A3 Methods and compositions for treating postoperative pain comprising nonsteroidal anti-inflammatory agents
04/22/2010WO2010009111A3 A drug depot implantable within a synovial joint
04/22/2010WO2010008224A3 Fast-dissolving amlodipine tablets of improved stability and a method of manufacture thereof
04/22/2010WO2010005726A3 Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
04/22/2010WO2010005725A3 Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same
04/22/2010WO2009154978A3 Self-preserved emulsions
04/22/2010WO2009148245A4 Novel niacin and hmg-coa reductase inhibitor combination formulation
1 ... 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 ... 2991